Pioneering computational peptide drug design using AI and atomic-level simulations to develop novel therapeutics.
ProteinQure is listed on Rocketlist with 1 active role. The company is categorized as Computational Drug Discovery in BioTech. ProteinQure is at Series A stage, with a B2B and B2C business model, headquartered in Toronto, Canada. ProteinQure was founded in 2017 and has 32 employees. ProteinQure has raised $16M. Active roles are refreshed daily from public hiring sources.